Meyka Pro banner
Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. (NYSE: CRL) Stock Competitors & Peer Comparison

See CRL's competitors and their performance on the NYSE and across the wider stock market.

CRL●NYSE
HealthcareMedical - Diagnostics & Research
$335.52
$5.29(1.55%)
U.S. Market opens in NaNh NaNm

Peer Comparison Table: Medical - Diagnostics & Research Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for CRL and its NYSE peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
CRL$337.97-0.83%16.2B34.14$9.90N/A
DHR-PB$1,261.26-0.78%916.8B146.01$8.64+0.65%
TMO$700.22+0.11%259.4B30.23$23.16+0.26%
DHR$233.02+0.37%164B29.21$7.98+0.65%
IDXX$704.23+0.89%55.5B49.52$14.22N/A
A$173.96+0.55%49.1B29.94$5.81+0.59%
NTRA$319.09-1.19%46.3B-241.73-$1.32N/A
WAT$460.25-0.42%45.2B33.64$13.68N/A
IQV$265.12-2.21%43.7B21.84$12.13N/A
MTD$1,738.91+0.46%34.6B39.97$43.51N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Danaher Corporation (NYSE: DHR-PB)

CRL vs DHR-PB Comparison November 2026

Charles River Laboratories International, Inc. (NYSE: CRL) plays a significant role within the Healthcare sector. Its performance on the NYSE reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, CRL stands at 16.2B. In comparison, DHR-PB has a market cap of 916.8B. Regarding current trading prices, CRL is priced at $337.97 on the NYSE, while DHR-PB trades at $1,261.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

CRL currently has a P/E ratio of 34.14, whereas DHR-PB's P/E ratio is 146.01. In terms of profitability, CRL's ROE is +0.01%, compared to DHR-PB's ROE of +0.08%. Regarding short-term risk, CRL is more volatile compared to DHR-PB. This indicates higher risk in terms of short-term price fluctuations for CRL.Check DHR-PB's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions